Dr. Stuart W. Adler II, M.D.
Cardiac Electrophysiology (Clinical Cardiac Electrophysiology Physician)
- Medicare participating
At a glance
- Medical school
- University of New Mexico School of Medicine (1985)
- Years since graduation
- 41
- In the NPI registry since
- 2005
- Medicare patients seen, 2024
- 845
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 1985Medical school: University of New Mexico School of Medicine
- 2005Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Clinical Cardiac Electrophysiology Physician primary
MN license 35553 -
Cardiovascular Disease Physician
MN license 35553
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- M Health Fairview St John's Hospital Maplewood, MN
- M Health Fairview Woodwinds Hospital Woodbury, MN
Medical groups
- Healtheast Medical Research Institute (649 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 845
- Services billed
- 1,883
- Patients’ average age
- 79
| Service | Times | Patients |
|---|---|---|
| Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 656 | 497 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 481 | 362 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 178 | 141 |
| Programming of dual lead pacemaker system | 144 | 138 |
| Electrocardiogram (ecg) 2-day continuous with review by health care professional | 79 | 78 |
| Established patient office or other outpatient visit, 40-54 minutes | 77 | 70 |
| Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional | 70 | 70 |
| Programming of multiple lead implantable defibrillator system | 50 | 44 |
| Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and tec | 44 | 27 |
| Evaluation of implantable heart and blood vessel monitoring system, remote up to 30 days | 43 | 27 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Eliquis (apixaban) Other prescribers in Saint PAul, MN | 200 |
| Metoprolol Succinate Other prescribers in Saint PAul, MN | 95 |
| Sotalol (sotalol hcl) Other prescribers in Saint PAul, MN | 70 |
| Xarelto (rivaroxaban) Other prescribers in Saint PAul, MN | 45 |
| Amiodarone Hcl Other prescribers in Saint PAul, MN | 34 |
| Flecainide Acetate Other prescribers in Saint PAul, MN | 33 |
| Losartan Potassium Other prescribers in Saint PAul, MN | 31 |
| Atorvastatin Calcium Other prescribers in Saint PAul, MN | 25 |
| Metoprolol Tartrate Other prescribers in Saint PAul, MN | 23 |
| Diltiazem 24hr Er (Cd) (diltiazem hcl) Other prescribers in Saint PAul, MN | 18 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 5 companies reported 6 payments worth $432 in total to this clinician.
| Biosense Webster, Inc. | $222 |
|---|---|
| Abiomed | $149 |
| Shockwave Medical, Inc | $22.95 |
| Cardiva Medical, Inc. | $21.36 |
| Boston Scientific Corporation | $17.03 |
| Food and Beverage | $432 |
|---|
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 3 industry-funded studies in 2025, from 2 companies. The companies reported $220,266 in research payments for these studies, mostly to the institutions running them.
- A Phase 3, Randomized, Double-Blind, Double-Dummy, Parallel Group, Active Controlled Study to Evaluate the Efficacy and Safety of Milvexian, an Oral Factor XIa Inhibitor, Versus Apixaban in Participants with Atrial Fi…
Janssen Research & Development, LLC - SIMPLAAFY Clinical Trial
Boston Scientific Corporation · Active, not recruiting · NCT06521463 - CHAMPION-AF Clinical Trial
Boston Scientific Corporation · Active, not recruiting · NCT04394546
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.